AGBL5 p.Arg489His
c.1466G>A · rs202108566 · VCV844256
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7815 | likely pathogenic |
|---|---|---|
| REVEL | 0.312 | indeterminate |
| SaProt | LLR -11.13 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.5, phastCons 1 |
| Regional constraint | o/e 0.80 | unconstrained · MANE · 4,357 bp · p 1.1e-07 · regional, not allelic |
| Overall | ||
| CADD | 32.0 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 0.11% | 912 |
| Middle Easterngrpmax | 0.099% | 1,010 |
| Remaining individualsnot grpmax-eligible | 0.0384% | 2,603 |
| South Asian | 0.0286% | 3,501 |
| Admixed American | 0.02% | 5,001 |
| European (non-Finnish) | 0.0194% | 5,152 |
| African / African-American | 0.008% | 12,505 |
| Ashkenazi Jewishnot grpmax-eligible | 0.00338% | 29,592 |
| Finnishnot grpmax-eligible | 0.00156% | 64,000 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- AGBL5
- Protein
- p.Arg489His
- Coding
- c.1466G>A
- MANE Select
- NM_021831
- dbSNP
- rs202108566
- Type
- single nucleotide variant
- Location
- chr2:27056723 (GRCh38)
- Gene constraint
- LOEUF 0.709 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 71.36 · 10 PDB
- Residue 489
- the peptidase m14 domain; a UniProt-annotated variant site (found in patients with a usher-like phenotype encompassing rp and hearing loss; likely pathogenic); a UniProt-annotated variant site (in rp75); a β-strand
Similar variants
- AGBL5 p.Arg489= Conflicting classifications of pathogenicity ★ same residue
- AGBL5 p.Trp592Ter Pathogenic ★★ same condition
- AGBL5 p.Arg147Cys Uncertain significance ★★ ⚠ same condition
- AGBL5 p.Arg341His Uncertain significance ★★ ⚠ same condition
- AGBL5 p.Arg487Gln Uncertain significance ★★ ⚠ same condition
- AGBL5 p.Arg537His Uncertain significance ★★ ⚠ same condition
- AGBL5 p.Arg598His Uncertain significance ★★ ⚠ same condition
- AGBL5 p.Arg673Trp Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/agbl5-p-arg489his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown